News & Updates | Alliance Healthcare UK

Updates

SUB-TYPE: CLASS 4 CAUTION IN USE

Class 4 Drug Alert (Caution in use only) Convulex 500mg Capusles

G.L. Pharma GmbH would like to inform Healthcare professionals that they are aware that there is an error on the carton for batches 5E048A and 5H155A in relation to the strength. Inadvertently, the information "Each capsule contains 150 mg valproic acid." was printed on one side of the cartons instead of the correct "Each capsule contains 500 mg valproic acid." All other information, especially the main headings on the package ("Convulex® capsules 500 mg"), however is correct on the carton. G.L. Pharma GmbH confirms that capsules are 500mg strength. The correct strength is also given on the primary blister pack and the patient information leaflet. G.L. Pharma GmbH have informed the MHRA and the MHRA have approved the continued distribution of batches 5E048A and 5H155A until replacement stock is available.

The affected products' details are as follows:

PIP Code	Product Description	Supplier	Affected Batches
0560656	Convulex 500mg Capusles	Pfizer Ltd	5E048A 5H155A

SUB-TYPE: COMPANY-LED RECALL

Company-Led Dotarem Solution for Injection 15ml

GUERBERT have issued a precautionary recall because a glass particle has been identified in one syringe from this batch..

Please visit the: MHRA website for more details on this drug alert.

The affected products' details are as follows:

PIP Code	Product Description	Supplier	Affected Batch
Alliance Healthcare Do Not Stock	Dotarem Solution for Injection 15ml	Guerbert	9263

For further stock enquiries please contact Guerbet Sales Department on 0121 7338542.

Recipients of this Drug Alert should bring it to the attention of relevant contacts.

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

If you have any questions, then please contact your local Service Centre Customer Services team.

SUB-TYPE: COMPANY-LED RECALL

Company-Led Drug Alert Fludarabine 25mg/ml, 1 x 2ml

Sandoz is recalling this batch because particulate matter, believed to be intrinsic to the active pharmaceutical ingredient, was identified in samples.

Please visit the: MHRA website for more details on this drug alert.

The affected products' details are as follows:

PIP Code	Product Description	Supplier	Affected Batch
Alliance Do Not Stock	Fludarabine 25mg/ml, 1 x 2ml	Sandoz Ltd	ER 4824

Alliance Healthcare do not stock and therefore we are not accepting stock returns.

Please contact Sandoz Customer Services for all enquiries relating to the issue on Telephone: 01276 698607

Recipients of this Drug Alert should bring it to the attention of relevant contacts.

If you have any questions, then please contact your local Service Centre Customer Services team.

SUB-TYPE: CLASS 4 CAUTION IN USE

Class 4 Drug Alert (Caution in use only) Genotropin Goquick 5.3mg and Genotropin Goquick 12mg

Pfizer Limited has notified us of a manufacturing defect in the dosing mechanism of some Genotropin GoQuick pens which are used to administer somatropin.

Please visit the: MHRA website for more details on this drug alert.

The affected products' details are as follows:

PIP Code	Product Description	Supplier	Affected Batch
3568979	Genotropin Goquick 12mg	Pfizer Ltd	All unexpired batches
3568961	Genotropin Goquick 5.3mg	Pfizer Ltd	All unexpired batches

This is a caution in use only and therefore we are not accepting stock returns.

Please contact Pfizer's endocrine helpline, tel 0800 521249; email endocrinecare@pfizer.com

Alternatively contact Pfizer Medical Information, tel 01304 616161

Recipients of this Drug Alert should bring it to the attention of relevant contacts.

If you have any questions, then please contact your local Service Centre Customer Services team.

SUB-TYPE: COMPANY-LED RECALL

Company-Led Drug Alert Pioglitazone Accord 30mg Tablets

Accord Healthcare Limited is recalling a specific batch which has inadvertently been distributed in the UK, because it is labelled for the Portuguese market.

Please visit the: MHRA website for more details on this drug alert.

The affected products' details are as follows:

PIP Code	Product Description	Supplier	Affected Batch
Alliance Do Not Stock	Pioglitazone Accord 30mg Tablets	Accord Healthcare Limited	P05615

Alliance Healthcare do not stock and therefore we are not accepting stock returns.

For stock enquiries, please contact Accord Healthcare Limited on 020 8939 3490

For Customer Services enquiries, please contact Accord Healthcare Limited on 020 8901 3507 / 020 8863 1427

Recipients of this Drug Alert should bring it to the attention of relevant contacts.

If you have any questions, then please contact your local Service Centre Customer Services team.

SUB-TYPE: COMPANY-LED RECALL

Company-Led Drug Alert Ambre Solaire

Garnier is recalling the above products of Ambre Solaire to patient level due to a 'Label Misprint'.

The affected products' details are as follows:

PIP Code	Product Description	Supplier	Affected Batches
3135522	Ambre sol clr prot spry f20 200ml	Garnier	All Batches
3135548	Ambre sol clr prot spry f30 200ml	Garnier	All Batches
3432903	Ambre sol lght&slk milk spf** 200ml	Garnier	All Batches
3432879	Ambre sol lght&slk milk spf30 200ml	Garnier	All Batches
3681285	Ambre sol milk spf30 50ml	Garnier	All Batches
3263555	Ambre solaire kids spray spf 50 200ml	Garnier	All Batches
3135506	Ambre sol clr prot spry** f10 200ml	Garnier	All Batches
3429370	Ambre sol kids rapido sprspf30 150ml	Garnier	All Batches

If you have any questions, then please contact your local Service Centre Customer Services team.

SUB-TYPE: CLASS 3 RECALL

Class 3 Drug Alert (action within 5 days) Exocin 3mg/ml Eye Drops (1 X 5ml)

Allergan UK Limited is recalling 'Danish Language Packs' of the above batch which have been shipped to the UK in error along with UK packs with the same batch number.

Please visit the: MHRA website for more details on this drug alert.

The affected products' details are as follows:

PIP Code	Product Description	Supplier	Affected Batch
0861989	Exocin 3mg/ml Eye Drops	Allergan Ltd	E75048
8076556	PI Exocin 3mg/ml Eye Drops	Allergan Ltd	E75048

For stock control enquiries please contact Allergan Customer Services Team on 0800 3767975

Recipients of this Drug Alert should bring it to the attention of relevant contacts.

If you have any questions, then please contact your local Service Centre Customer Services team.

SUB-TYPE: CLASS 4 CAUTION IN USE

Class 4 Drug Alert (Caution in use only) Epilim 200 & 500mg And Sodium Valproate

Sanofi UK have been made aware of an unusual odour associated with the above batches of Epilim / Sodium Valproate Gastro-resistant tablets. The odour has variously been described as ‘fishy', ‘sweaty armpits' and ‘cannabis'. An investigation by Sanofi has identified the root cause as the aluminium foil used in the packaging of affected batches. No impact on the quality or efficacy of the tablets has been detected. Sanofi has now ceased using this foil supplier.

Please visit the: MHRA website for more details on this drug alert.

The affected products' details are as follows:

PIP CodeProduct DescriptionSupplierAffected Batches

0269803Epilim Ec Tab 200mgSanofi UKJ601
J602
J603
K1
K2
K3
K7

0173534Epilim Ec Tab 500mgSanofi UKJ602
J603
K1
K2

Alliance do not stockSodium Val Tab 200mgZentivaK1

Alliance do not stockSodium Val Tab 500mgZentivaJ601

For all enquiries about this matter, please contact Sanofi Medical Information on 0845 3727101 or email UK-medicalinformation@sanofi.com

If you have any questions, then please contact your local Service Centre Customer Services team.

SUB-TYPE: COMPANY-LED RECALL

Company-Led Drug Alert Vitaros 3mg/G X 4

Takeda UK Limited is recalling the below batch of Vitaros 3mg/G X 4 because this batch was distributed to the UK market in error between 3rd March and 11th March 2015..

Please visit the: GOV.UK website for more details on this drug alert.

The affected products' details are as follows:

PIP Code	Product Description	Supplier	Affected Batch
3845286	Vitaros 3mg/G X 4	Takeda UK Limited	511742

For enquiries relating to stock return, please call your local Alliance Healthcare Limited Local Service Centre Customer Services Team.

For medical information enquiries, please contact Takeda on tel 01628 537900, email DSO-UK@takeda.com, fax 01628 526617.

Recipients of this Drug Alert should bring it to the attention of relevant contacts.

If you have any questions, then please contact your local Service Centre Customer Services team.

SUB-TYPE: COMPANY-LED RECALL

Company-Led Drug Alert Rienso 30mg/ml solution for infusion

Takeda UK Limited is recalling the above batches because the patient information, carton and vial label have been updated to reflect the changed mode of administration from injection to infusion.

Please visit the: MHRA website for more details on this drug alert.

The affected products' details are as follows:

PIP Code	Product Description	Supplier	Affected Batch
Alliance Do Not Stock	Rienso 30mg/ml solution for infusion	Takeda UK Ltd	240789 257893

Company contact for medical information enquiries:

Takeda UK Ltd
Tel: 01628 537900
Fax: 01628 526617
Email: DSO-UK@takeda.com

Recipients of this Drug Alert should bring it to the attention of relevant contacts.

If you have any questions, then please contact your local Service Centre Customer Services team.